Influence of histon deacetyrase inhibitor in induction of tumor-associated stroma in oral cancer cell line.
| Project/Area Number |
20791344
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Morphological basic dentistry
|
|---|
| Research Institution | Nihon University |
|---|
Principal Investigator |
MATSUMOTO Naoyuki Nihon University, 歯学部, 助教 (20386080)
|
|---|
| Co-Investigator(Renkei-kenkyūsha) |
小宮山 一雄 日本大学, 歯学部, 教授 (00120452)
我孫子 宜光 日本大学, 松戸歯学部, 教授 (70050086)
|
|---|
| Project Period (FY) |
2008 – 2009
|
| Project Status |
Completed (Fiscal Year 2009)
|
| Budget Amount *help |
¥2,470,000 (Direct Cost: ¥1,900,000、Indirect Cost: ¥570,000)
Fiscal Year 2009: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2008: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
|---|
| Keywords | 癌 / リンパ管新生 / 血管新生 / 腫瘍問質誘導 / DNA転写調節 / 転移 / 腫瘍間質誘導 |
|---|
| Research Abstract |
We investigated the effect of sodium butyrate (SB), one of histone deacetylase inhibitor on oral cancer cells. RNA and protein expression level of angiogenic- and lymphangiogenic-factors are assessed. Expression level of angiopoietin-2, platelet derived growth factor beta, VEGF-C, VEGF-D are downregulated by SB stimulation. These findings indicating its potential use in anti-angiogenic and -lymphangiogenic cancer therapy. Interestingly, agiogenic factor VEGF-A and transcription regulator COX-2 are upregulated. Now, we investigated detail of the mechanism.
|
Report
(3 results)
Research Products
(1 results)
